Fig. 4From: Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot studyLCN2 serum concentrations rise in the active, but not placebo-treated group approximately 9 months after end of sublingual treatment. LCN2-concentration and total nasal symptom scores (TNSS) in (a) active and (b) placebo-treated participants. Statistical analyses were conducted using one-way ANOVA using Tukey’s multiple comparisons test for post-hoc analyses. **** p < 0.0001, *** p < 0.001Back to article page